全文获取类型
收费全文 | 232104篇 |
免费 | 19888篇 |
国内免费 | 6416篇 |
专业分类
耳鼻咽喉 | 1822篇 |
儿科学 | 4642篇 |
妇产科学 | 2704篇 |
基础医学 | 13997篇 |
口腔科学 | 3739篇 |
临床医学 | 31571篇 |
内科学 | 34674篇 |
皮肤病学 | 2935篇 |
神经病学 | 19822篇 |
特种医学 | 7446篇 |
外国民族医学 | 46篇 |
外科学 | 22491篇 |
综合类 | 38150篇 |
现状与发展 | 28篇 |
一般理论 | 9篇 |
预防医学 | 14218篇 |
眼科学 | 3480篇 |
药学 | 19616篇 |
253篇 | |
中国医学 | 16887篇 |
肿瘤学 | 19878篇 |
出版年
2024年 | 498篇 |
2023年 | 3972篇 |
2022年 | 6326篇 |
2021年 | 10302篇 |
2020年 | 10020篇 |
2019年 | 8745篇 |
2018年 | 8151篇 |
2017年 | 9264篇 |
2016年 | 9613篇 |
2015年 | 8985篇 |
2014年 | 16475篇 |
2013年 | 19221篇 |
2012年 | 13732篇 |
2011年 | 14409篇 |
2010年 | 11856篇 |
2009年 | 10994篇 |
2008年 | 10985篇 |
2007年 | 11752篇 |
2006年 | 10457篇 |
2005年 | 9189篇 |
2004年 | 7462篇 |
2003年 | 6693篇 |
2002年 | 5585篇 |
2001年 | 4966篇 |
2000年 | 4036篇 |
1999年 | 3214篇 |
1998年 | 2713篇 |
1997年 | 2481篇 |
1996年 | 2074篇 |
1995年 | 1938篇 |
1994年 | 1626篇 |
1993年 | 1256篇 |
1992年 | 1254篇 |
1991年 | 1065篇 |
1990年 | 903篇 |
1989年 | 786篇 |
1988年 | 741篇 |
1987年 | 700篇 |
1986年 | 537篇 |
1985年 | 624篇 |
1984年 | 537篇 |
1983年 | 375篇 |
1982年 | 401篇 |
1981年 | 322篇 |
1980年 | 256篇 |
1979年 | 253篇 |
1978年 | 194篇 |
1977年 | 106篇 |
1976年 | 121篇 |
1975年 | 84篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
目的:探讨血化瘀方联合针灸治疗对脑梗后遗症患者脑血管血液流变动力学及神经功能的影响。方法:选取2016年1月至2017年1月沈阳市第二中医医院收治脑梗后遗症患者120例作为研究对象,对照组61例患者接受针灸治疗;观察组59例患者接受活血化瘀方联合针灸治疗。2组连续治疗30 d。比较2组患者脑血流流变学指标、神经功能评分、中医证候积分、临床疗效。结果:治疗前2组患者脑部平均血流速度、左侧椎动脉血流量、右侧椎动脉血流量、基底动脉血流量比较,差异无统计学意义(P 0. 05)。治疗后观察组患者脑部平均血流速度、左侧椎动脉血流量、右侧椎动脉血流量、基底动脉血流量大于对照组(P 0. 05)。治疗前2组患者NIHSS评分、MMSE评分比较,差异无统计学意义(P 0. 05)。治疗后观察组患者NIHSS评分显著低于对照组,MMSE评分高于对照组(P 0. 05)。治疗前2组患者头晕目眩、语言謇涩、半身不遂、患侧麻木、舌苔白腻证候评分比较,差异无统计学意义(P 0. 05)。治疗后研究患者头晕目眩、语言謇涩、半身不遂、患侧麻木、舌苔白腻证候评分显著低于对照组(P 0. 05)。2组患者临床疗效比较,差异有统计学意义(Z=-5. 626,P=0. 000)。结论:活血化瘀方联合针灸能改善脑梗后遗症患者脑血管血液流变动力学指标,保护神经功能。 相似文献
23.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
24.
25.
26.
27.
28.
29.
《Sleep medicine》2020
ObjectivesPrior evidence suggests that sleep duration and sleep difficulties may be associated with cognitive function in old age, but little is known about the sleep–cognition association in late mid-life. Our aim was to examine the associations of accelerometer-based sleep duration as well as subjective sleep difficulties with different domains of cognitive function among aging workers.MethodsThe study population consisted of 289 participants (mean age 62.4 years, SD 1.02; 83% women) from the Finnish Retirement and Aging Study (FIREA). Sleep difficulties were measured using Jenkins Sleep Problem Scale (difficulties falling asleep, difficulties maintaining sleep, waking up too early in the morning, and nonrestorative sleep). Sleep duration was measured with wrist-worn accelerometer and self-report, and participants were divided into short (<7 h/night), mid-range (7–9 h/night) and long (≥9 h/night) sleepers. Participants underwent extensive cognitive testing covering three domains: (1) memory, (2) executive function, and (3) attention and information processing.ResultsGreater difficulties in waking up too early in the morning were associated with poorer executive function measured with Spatial Working Memory (SWM) test (p = 0.005). Additionally, nonrestorative sleep was associated with poorer executive function measured with Trail Making Test, B–A, (p = 0.036) and borderline significantly with lower SWM (p = 0.056). Compared to mid-range sleepers, long sleepers tended to have poorer cognitive function (all memory function tests and SWM), but the associations were not statistically significant due to small number of long sleepers.ConclusionsSubjective sleep difficulties may be linked to poorer executive function in a relatively healthy population of older workers in their 60 s. Thus, promoting good sleep quality may translate into better cognitive health in late mid-life. 相似文献
30.
Platelets are needed to prevent or arrest bleeding and aggregate at the site of injury upon vascular damage. Platelets express receptors for estrogens which might affect the function of the platelets and their hemostatic ability. The aim was to identify possible differences in platelet function related to age, gender, and phases of the menstrual cycle by use of impedance aggregometry with Multiplate. In the first part of the study, platelet function was assessed in 60 healthy individuals (30 men and 30 women) in each of three age groups (20–25, 40–45, and 60–65 years). In the second part of the study, the platelet function was analyzed on four occasions during the menstrual cycle in women without oral contraceptives (OCs) (n = 17) and compared to 19 women on OCs and 18 men of similar age (20–40 years). For the women on OCs, aggregation was analyzed once during the tablet-free week and once late during the period with OCs. The men were sampled once. Women of younger age (<45 years) had significantly higher agonist-induced aggregation response than both men and post-menopausal women (60–65 years). The agonist-induced aggregation response did not differ between phases of the menstrual cycle or OC use. The results suggest that estradiol and/or progesterone affect spontaneous aggregation since it was found to be lowest in the mid-luteal phase. Spontaneous aggregation was significantly lower in women on OCs than in both men and women without OCs. Our findings indicate that fertile age is associated with higher aggregation response capacity of the platelets, possibly to prevent excessive bleeding during menstruation, but this response capacity is not altered during the menstrual cycle or by use of OCs. 相似文献